The Absorption, Metabolism and Excretion of [14C]APG-2575 in Healthy Subjects
Clinical trial NCT05517616 · COMPLETED
Trial details
- NCT number
- NCT05517616
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2022-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.